GBH - YOUNGSTOWN — History
CCN 364060 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+19.8%
Revenue CAGR (3yr)
23.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $14M | $18M | $20M | +10.6% | +19.8% |
| Operating Expenses | $14M | $14M | $15M | +11.2% | +5.5% |
| Operating Margin | 0.8% | 23.5% | 23.0% | -1.8% | +430.0% |
| Net Income | $0M | $4M | $4M | +8.6% | +534.8% |
| Licensed Beds | 76 | 76 | 76 | +0.0% | +0.0% |
| Total Patient Days | 19,703 | 20,041 | 22,469 | +12.1% | +6.8% |
| Medicare Day % | 22% | 18% | 17% | -5.3% | -12.8% |
| Medicaid Day % | 0% | 0% | 0% | +57.2% | -13.6% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +43.4% ($14M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+19.8%
This Hospital
+7.6%
State Avg
Latest Margin
23.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $22M | 34.1% |
| FY2024 (proj) | $25M | 45.2% |
| FY2025 (proj) | $28M | 56.3% |